Factor V Leiden / Prothrombin Gene Mutation Analysis

The procurement process for the "Factor V Leiden / Prothrombin Gene Mutation Analysis" is managed by Warrington and Halton Teaching Hospitals NHS Foundation Trust. It falls under the services category, specifically pathology services, and is located in the United Kingdom. The procurement was conducted through a direct award process, confirmed under the Health Care Services (Provider Selection Regime) Regulations 2023.

This contract has been awarded and began on 16th July 2025, running until 31st March 2027, with an estimated total value of £3,500. This process was carried out without a prior publication of a call for competition, as it fell outside the scope of the Public Contracts Regulations 2015. This tender presents an opportunity for growth, particularly for businesses involved in pathology services.

It is well-suited for established organisations with the capacity to provide specialised genetic mutation testing services. The contract's limited procurement method indicates that it was tailored for specific providers, potentially favouring those with existing relationships or specialised expertise in healthcare services. Companies looking to establish themselves in the NHS supply chain or expand their offerings in health-related services should consider exploring similar future procurements for partnership and service provision opportunities.